
Kirby Mcinerney LLP Urges Investors In Manhattan Associates, Inc. (MANH) To Inquire About Their Rights In Class Action Lawsuit
[LEARN MORE ABOUT THE CLASS ACTION]
On January 28, 2025, Manhattan published its financial results for the fourth quarter and full fiscal year 2024 and announced reduced revenue guidance for the full fiscal year 2025. The Company attributed its results and lowered guidance on the“shift in professional services work to future periods...and to a lesser extent, reduced customization and higher partner utilization.” On this news, the price of Manhattan shares declined by $72.26 per share, or approximately 24%, from $295.10 per share on January 28, 2025, to close at $222.84 on January 29, 2025.
The complaint alleges that defendants, throughout the Class Period, failed to disclose the true state of Manhattan's forecasting ability for its professional services; notably, the Company was either not truly equipped to deliver“responsible targets” for growth or, otherwise, Manhattan's services were not equipped to achieve such targets.
If you purchased or otherwise acquired Manhattan securities, have information, or would like to learn more about this investigation, please contact Thomas W. Elrod of Kirby McInerney LLP by email at ... , or fill out the form below, to discuss your rights or interests with respect to these matters without any cost to you.
[CONTACT FORM]
Kirby McInerney LLP is a New York-based plaintiffs' law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm's efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP's website .
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
...


Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Comments
No comment